DNA and Gene Cloning Services Market Size, Scope, Forecast Report 2026 to 2035
What is DNA and Gene Cloning Services Market Size?
Global DNA and Gene Cloning Services Market Size is valued at USD 3.68 Bn in 2025 and is predicted to reach USD 17.49 Bn by the year 2035 at a 17.0% CAGR during the forecast period for 2026 to 2035.
DNA and Gene Cloning Services Market Size, Share & Trends Analysis Report By Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of company size, Type of Gene, End-User Industry, By Region, And By Segment Forecasts, 2026 to 2035.
DNA and Gene Cloning Services Market Key Takeaways:
|
Key Industry Insights & Findings from the Report:
- One of the major factors supporting the growth of the gene cloning services market is the increasing number of chronic and infectious diseases.
- The growing advancement in technology in cloning & sub-cloning services is boosting the growth of the gene cloning services market.
- North America dominated the market and accounted for a global revenue share in 2024.
- The key challenge for the DNA and gene cloning services market is the need to address the increasing demand for personalized medicine.
The progress of genetic engineering and cloning techniques has made it possible to alter the genomes of microorganisms, allowing for synthesizing compounds with diverse research and medicinal applications. A method that assembles DNA sequences of interest by cutting and pasting them together using enzymes. The recombined DNA sequences can be inserted into vectors, molecules that transport DNA into a host cell. The specific recombined DNA sequence can be replicated or translated within this host cell. Gene probes produced using gene cloning offer a range of applications, including early detection of genetic disorders, forensic investigations, and routine diagnosis. This technology's industrial application gives novel antibiotics in the form of antimicrobial peptides and recombinant cytokines that can be employed as therapeutic agents.
Also, with the help of the cloning technique, It is possible to isolate a specific gene and identify its nucleotide sequence, and DNA control sequences can be found and examined. The function of proteins, enzymes, and RNA can be studied, and Mutations are detectable. Cloning techniques at the molecular level are fundamental to a wide variety of scientific fields in modern biology and medicine.
The market for DNA cloning and gene cloning services is expected to experience consistent growth in the years to come as a result of the rising demand for gene therapies and the introduction and adoption of novel and advanced DNA cloning technologies. These two factors are expected to drive the market for DNA cloning and gene cloning services. A favourable funding landscape for gene synthesis and cloning services, technological improvement in cloning and subcloning services, and an increase in synergistic activities in the market are some of the factors supporting the market's growth. In Aug 2020, Thermo Fisher revealed a $76 million expansion at its US location as part of its ongoing $650 million bioprocessing revamp.
While the worldwide gene synthesis market is expected to proliferate over the next few years, its development may be limited by a lack of qualified professionals and lengthy approval processes. Growth prospects may arise as a result of technological developments, strategic partnerships, and mergers and acquisitions in the biomedical and healthcare industries.
Competitive Landscape:
Some Major Key Players In The DNA And Gene Cloning Services Market:
- Bio-Techne,
- Charles River Laboratories,
- Curia,
- Eurofins,
- GenScript,
- Integrated DNA Technologies,
- MedGenome,
- Sino Biological,
- Syngene,
- Twist Bioscience,
- Thermo Fisher Scientific Inc.,
- Eurofins Scientific,
- Merck KGaA,
- Takara Bio Inc.,
- Lonza,
- Sartorius AG,
- Creative Biogene,
- Cellecta, Inc.,
- Synbio Technologies,
- TransGen Biotech Co., Ltd.,
- Dobuss (Canvax),
- Azenta US, Inc.,
- Macrogen, Inc.,
- Codex DNA, Inc.,
- Bio-Rad
Market Segmentation:
The DNA and Gene Cloning Services market is segmented into three main aspects, the type of services offered, which comprises Custom cloning, gene synthesis, sub-cloning and others. Type of Company Size includes Small, Mid-size, and Large. The third segment is the type of gene that includes complex gene and standard gene as sub-segments. The fourth significant segment is the end-user industry, and this comprises Academic and R&D, Pharmaceutical and Biotechnology Companies and other industries.
DNA and gene cloning are currently receiving a lot of attention in the life science research market in North America, which has led to increased investments, funding, and collaborations for industrial expansion in the foreseeable future.
Recent Developments:
- In Sept 2023, Bio-Rad Laboratories, Inc., a prominent multinational company specializing in life science research and clinical diagnostic devices, has just introduced the PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers. The purpose of these heat cyclers is to facilitate PCR applications in fundamental and applied research, process optimization, and quality assurance.
DNA and Gene Cloning Services Market Report Scope:
| Report Attribute | Specifications |
| Market Size Value In 2025 | USD 3.68 Bn |
| Revenue Forecast In 2035 | USD 17.49 Bn |
| Growth Rate CAGR | CAGR of 17.0% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Type of Service Offered, Type of Company Size Type of Gene, End-User Industry |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ; France; Italy; Spain; South Korea; South East Asia; |
| Competitive Landscape | Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Twist Bioscience, Thermo Fisher Scientific Inc., Eurofins Scientific, GenScript, Merck KGaA, Takara Bio Inc., Lonza, Sartorius AG, Creative Biogene, Cellecta, Inc., Synbio Technologies, TransGen Biotech Co., Ltd., Dobuss (Canvax), Azenta US, Inc., Macrogen, Inc., Codex DNA, Inc., Bio-Rad, and other key players. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation Of DNA and Gene Cloning Services Market
Global DNA and Gene Cloning Services Market, by Type of Service Offered
- Custom Cloning
- Gene Synthesis
- Sub-cloning
- Others
Global DNA and Gene Cloning Services Market, by Type of Company Size
- Small
- Medium
- Large
Global DNA and Gene Cloning Services Market, by Type of Gene
- Complex Gene
- Standard Gene
- Others
Global DNA and Gene Cloning Services Market, by End-User Industry
- Academic and R&D
- Pharmaceutical and Biotechnology Companies
- Others
Global DNA and Gene Cloning Services Market, by Region
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
DNA and Gene Cloning Services Market is expected to grow at a 17.0% CAGR during the forecast period for 2026-2035.
Bio-Techne, Charles River Laboratories, Curia, Eurofins, GenScript, Integrated DNA Technologies, MedGenome, Sino Biological, Syngene, Others
DNA and Gene Cloning Services Market Size is valued at USD 3.68 Bn in 2025 and is predicted to reach USD 17.49 Bn by the year 2035.
DNA and Gene Cloning Services market is segmented into three main aspects, the type of services offered, which comprises Custom cloning, gene synthesis, sub-cloning and others.
North America region is leading the DNA and Gene Cloning Services Market.